|
The Immunohistochemistry Antibody Company
|
- Home
-
Products
- All Antibodies
- IHC-plus Antibodies
-
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
- Distributors
-
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
-
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us
|
|
General Cancer Screen 171 Tissue Microarray - LS-SCA171
This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.
|
|
| Catalog ID: |
LS-SCA171 |
| Product Name: |
General Cancer Screen 171 |
| Description: |
Various cancers (12 types) with stage/grade and adjacent normal/non-neoplastic specimens |
| Format: |
FFPE |
| Category: |
Human Tumor and Adjacent Normal |
| QA/QC: |
H&E reviewed |
| Storage: |
Short term RT; Long term 4ºC |
| Clinical History: |
No |
| Tissue Marker: |
No |
| Stage/Grade: |
Yes |
| Cases: |
16 |
| Cores: |
24 |
| Slides Per Set: |
1 |
LS-SCA171 Tissue Microarray Map
Slide Number 1
| LABEL | | | 1 | 2 | 3 | 4 | 5 | 6 | | A | Pst | Pst | Lng | Lng | Col | Col | | B | Bst | Bst | Tyd | Tyd | Pnc | Pnc | | C | Lym | Lym | Bla | Bla | Tng | Tng | | D | Lrx | Lrx | Tes | Tes | Str | Skl |
|
Diagnosis Type Legend| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue LegendBladder (Bla); Breast (Bst); Colon (Col); Larynx (Lrx); Lung (Lng); Lymph node (Lym); Pancreas (Pnc); Prostate (Pst); Skeletal muscle (Skl); Striated muscle, Face (Str); Testis (Tes); Thyroid (Tyd); Tongue (Tng);
LS-SCA171 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | Gleason Score | TNM Tumor Classification | Tumor Grade | Tumor Stage |
|---|
| 1 | A1 | Human | M | 66 y | Prostate (Pst) | Adenocarcinoma | Malignant | 5+5 | T2N0M0 | 3 | II |
| 1 | A2 | Human | M | 27 y | Prostate (Pst) | Adjacent normal with hyperplasia | Diseased | | | | |
| 1 | A3 | Human | M | 62 y | Lung (Lng) | Squamous cell carcinoma | Malignant | | T2N1M0 | 2 | II |
| 1 | A4 | Human | M | 62 y | Lung (Lng) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | A5 | Human | M | 47 y | Colon (Col) | Adenocarcinoma | Malignant | | T4N1M0 | 2 | III |
| 1 | A6 | Human | M | 47 y | Colon (Col) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | B1 | Human | F | 44 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | | T2N1M0 | 1 | IIB |
| 1 | B2 | Human | F | 44 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | B3 | Human | M | 56 y | Thyroid (Tyd) | Papillary carcinoma | Malignant | | T2N0M0 | | II |
| 1 | B4 | Human | M | 56 y | Thyroid (Tyd) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | B5 | Human | F | 73 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | | T2N0M0 | 3 | II |
| 1 | B6 | Human | F | 73 y | Pancreas (Pnc) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | C1 | Human | F | 64 y | Lymph node (Lym) | Diffuse large B cell lymphoma | Malignant | | | | |
| 1 | C2 | Human | M | 56 y | Lymph node (Lym) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | C3 | Human | M | 67 y | Bladder (Bla) | Urothelial carcinoma | Malignant | | T3aN0M0 | 2-3 | II |
| 1 | C4 | Human | M | 67 y | Bladder (Bla) | Adjacent normal with cystitis | Diseased | | | | |
| 1 | C5 | Human | F | 39 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | | T1N0M0 | 1 | I |
| 1 | C6 | Human | F | 51 y | Tongue (Tng) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | D1 | Human | M | 68 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | | T3N1M0 | 1 | III |
| 1 | D2 | Human | M | 68 y | Larynx (Lrx) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | D3 | Human | M | 50 y | Testis (Tes) | Seminoma | Tumor | | T1N0M0 | | I |
| 1 | D4 | Human | M | 70 y | Testis (Tes) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | D5 | Human | F | 34 y | Striated muscle, Face (Str) | Rhabdomyosarcoma, Pleomorphic | Malignant | | T1aN0M0 | | IIA |
| 1 | D6 | Human | F | 21 y | Skeletal muscle (Skl) | Normal | Benign non-neoplastic | | | | |
Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved
